Tech Company Financing Transactions
Arcion Therapeutics Funding Round
On 1/9/2008, Arcion Therapeutics raised $8.8 million in Series A financing from InterWest Partners and Presidio Partners.
Transaction Overview
Company Name
Announced On
1/9/2008
Transaction Type
Venture Equity
Amount
$8,800,000
Round
Series A
Investors
InterWest Partners (Lead Investor) (Arnold Oronsky)
Presidio Partners (Lead Investor) (David Collier)
Proceeds Purpose
The funding will help the company continue its breakthrough work with ARC-4558 (topical clonidine gel), a treatment for alleviating moderate and severe pain associated with diabetic neuropathy.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2400 Boston St. 330
Baltimore, MD 21224
USA
Baltimore, MD 21224
USA
Phone
Website
Email Address
Overview
This website is for sale! arciontherapeutics.com is your first and best source for all of the information you're looking for. From general topics to more of what you would expect to find here, arciontherapeutics.com has it all. We hope you find what you are searching for!
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
David Collier
Chief Executive Officer
James Campbell
Chief Operating Officer
Kerrie Brady
VP - Regulatory Affairs
William Schmidt
Browse more venture capital transactions:
Prev: 1/9/2008: Quantivo venture capital transaction
Next: 1/10/2008: Meteor Solutions venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs